Cleared Traditional

K260973 - InferOperate Suite

K260973 is the FDA 510(k) clearance for InferOperate Suite by Beijing Infervision Healthcare Medical Technology Co., Ltd.. It is a Class 2 Radiology device (product code QIH) cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K260973 · Beijing Infervision Healthcare Medical Technology Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2026
Decision
105d
Days
Class 2
Risk

K260973 is an FDA 510(k) clearance for the InferOperate Suite. Classified as Automated Radiological Image Processing Software within the QIH classification (a category dominated by AI-based automated radiology processing systems), Class II - Special Controls.

Submitted by Beijing Infervision Healthcare Medical Technology Co., Ltd. (Beijing, CN). The FDA issued a Cleared decision on July 7, 2026 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Beijing Infervision Healthcare Medical Technology Co., Ltd. devices

Submission Details

510(k) Number K260973 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 24, 2026
Decision Date July 07, 2026
Days to Decision 105 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
2d faster than avg
Panel avg: 107d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QIH Automated Radiological Image Processing Software
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
Definition To Provide Automated Radiological Image Processing And Analysis Tools. Software Implementing Artificial Intelligence Including Nonadaptive Machine Learning Algorithms Trained With Clinical And/or Artificial Data. In These Devices, The Algorithm Training Data Typically Impacts Device Performance. Adaptive Ai Algorithms Are Not Within Scope Of This Product Code.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - QIH Automated Radiological Image Processing Software

All 298
Devices cleared under the same product code (QIH) and FDA review panel - the closest regulatory comparables to K260973.
syngo.CT Coronary Cockpit
K253786 · Siemens Medical Solutions USA, Inc. · Jun 2026
DEEPVESSEL Plaque
K260497 · Keya Medical Technology Co., Ltd. · Jun 2026
OrthoGrid Hip AI® 4.0
K260077 · OrthoGrid Systems, Inc. · May 2026
ANDI 2.2
K261405 · Imeka Solutions, Inc. · May 2026
Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning
K260324 · Canon Medical Informatics, Inc. · May 2026
BAC
K254131 · DeepHealth, Inc. · May 2026